Viridian Therapeutics, Inc. Common Stock
$20.47
▼ 0.19
(-0.92%)
Volume: 2,090,645
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
34
- 21d momentum -15.6%
- RSI 37
🎯
Pullback
62
- Near lower Bollinger band
- -7.8% vs 20MA
💎
Value
58
- -40% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)37.4
MACD-0.269
MA trendMixed
ATR4.43%
21d mom.-15.6%
63d mom.+14.4%
vs 20MA-7.8%
RVOL(20)1.31×
52w low · 13
52w high · 34
-40.3% from 52-week high
20d support 20
· resistance 24
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$2.3B
PER—
PBR3.54
PSR32.91
EPS$-2.95
ROE-50.5%
ROA-30.4%
Dividend yield0.00%
Debt/Equity0.54
EV/EBITDA-6.24
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -6.95% | -15.62% | +14.36% | -27.41% | +4.97% | -33.28% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -10.69%, daily vol 2.39%. Viridian Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.